Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Rising AI Chip Demand to Boost Taiwan Semiconductor's Q3 Revenues
Rising AI Chip Demand to Boost Taiwan Semiconductor's Q3 Revenues

Taiwan Semiconductor Manufacturing Company Ltd. TSM is scheduled to release its third-quarter 2025 earnings on Oct. 16. The world’s top contract chipmaker looks well-positioned for another strong

Here's How Much a $1000 Investment in Emcor Group Made 10 Years Ago Would Be Worth Today
Here's How Much a $1000 Investment in Emcor Group Made 10 Years Ago Would Be Worth Today

How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors

Here's How Much a $1000 Investment in B2Gold Made 10 Years Ago Would Be Worth Today
Here's How Much a $1000 Investment in B2Gold Made 10 Years Ago Would Be Worth Today

For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and

Micron Soars 171% in Six Months: Is MU Stock Still Worth Buying?
Micron Soars 171% in Six Months: Is MU Stock Still Worth Buying?

Micron Technology, Inc. MU has delivered a robust 171.4% gain over the past six months. This performance easily beats the broader Zacks Computer and Technology sector, which rose 39.4% in the same

Sono-Tek Corporation (SOTK) Q2 Earnings Beat Estimates
Sono-Tek Corporation (SOTK) Q2 Earnings Beat Estimates

Sono-Tek Corporation (SOTK) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.02 per share a year ago

FDA Extends Review of DNLI's Hunter Syndrome Drug by Three Months
FDA Extends Review of DNLI's Hunter Syndrome Drug by Three Months

Denali Therapeutics Inc. DNLI announced that the FDA has extended its review timeline of the Biologics License Application (“BLA”) for pipeline candidate, tividenofusp alfa.

The BLA is seeking

Fastenal Stock Pulls Back in October—Is It Time to Buy FAST?
Fastenal Stock Pulls Back in October—Is It Time to Buy FAST?

Fastenal Company (NASDAQ: FAST) stock is pulling back in October, and the Q3 results aren’t helping with support. However, the problem isn’t with growth, profitability, or capital returns so

Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?
Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?

It is never too late to invest in mutual funds for retirement. As such, if you plan to invest in some of the best funds, the Zacks Mutual Fund Rank can provide you with valuable guidance.

The

3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio
3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio

Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.

The easiest way to judge a

3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio
3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio

There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.

The easiest, most

Rare Earth ETF (REMX) Hits New 52-Week High
Rare Earth ETF (REMX) Hits New 52-Week High

For investors seeking momentum, VanEck Rare Earth/Strategic Metals REMX is probably on the radar. The fund just hit a 52-week high and has soared 136% from its 52-week low of $32.36 per share. 

Are

Oil Demand Resilience Shines in OPEC's Latest Market View
Oil Demand Resilience Shines in OPEC's Latest Market View

OPEC’s latest Monthly Oil Market Report offered a steady and confident tone, keeping its global demand growth forecasts unchanged for both 2025 and 2026. The cartel continues to expect demand to

3 Crypto-Centric Stocks to Buy on the Dip Before Bitcoin Resumes Rally
3 Crypto-Centric Stocks to Buy on the Dip Before Bitcoin Resumes Rally

The cryptocurrency market suffered a bloodbath on Friday, with nearly $500 billion getting wiped out as panic gripped Wall Street after President Donald Trump threatened 100% tariffs on China

3 Reasons OKLO's All-Time High Close May Prove Short-Lived
3 Reasons OKLO's All-Time High Close May Prove Short-Lived

Sam Altman-backed Oklo Inc. OKLO has been one of 2025’s most remarkable stock stories. The nuclear microreactor developer’s share price has soared from about $20 in April to over $170 — a stunning

Buy 5 Consumer Discretionary Stocks With Solid Upside Potential for Q4
Buy 5 Consumer Discretionary Stocks With Solid Upside Potential for Q4

The consumer discretionary sector witnessed moderate growth in the first three quarters of 2025, despite a strong rally in U.S. stock markets. The situation is likely to improve in the fourth

Wells Fargo (WFC) Q3 Earnings and Revenues Surpass Estimates
Wells Fargo (WFC) Q3 Earnings and Revenues Surpass Estimates

Wells Fargo (WFC) came out with quarterly earnings of $1.73 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.52 per share a year ago. These figures

JPMorgan Chase & Co. (JPM) Tops Q3 Earnings and Revenue Estimates
JPMorgan Chase & Co. (JPM) Tops Q3 Earnings and Revenue Estimates

JPMorgan Chase & Co. (JPM) came out with quarterly earnings of $5.07 per share, beating the Zacks Consensus Estimate of $4.83 per share. This compares to earnings of $4.37 per share a year ago

Johnson & Johnson (JNJ) Beats Q3 Earnings and Revenue Estimates
Johnson & Johnson (JNJ) Beats Q3 Earnings and Revenue Estimates

Johnson & Johnson (JNJ) came out with quarterly earnings of $2.8 per share, beating the Zacks Consensus Estimate of $2.77 per share. This compares to earnings of $2.42 per share a year ago. These

FB Financial (FBK) Surpasses Q3 Earnings and Revenue Estimates
FB Financial (FBK) Surpasses Q3 Earnings and Revenue Estimates

FB Financial (FBK) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $0.86 per share a year ago. These

Domino's Pizza (DPZ) Tops Q3 Earnings and Revenue Estimates
Domino's Pizza (DPZ) Tops Q3 Earnings and Revenue Estimates

Domino's Pizza (DPZ) came out with quarterly earnings of $4.08 per share, beating the Zacks Consensus Estimate of $3.96 per share. This compares to earnings of $4.19 per share a year ago. These

Unity Bancorp (UNTY) Q3 Earnings and Revenues Surpass Estimates
Unity Bancorp (UNTY) Q3 Earnings and Revenues Surpass Estimates

Unity Bancorp (UNTY) came out with quarterly earnings of $1.33 per share, beating the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $1.07 per share a year ago. These

BlackRock (BLK) Q3 Earnings and Revenues Surpass Estimates
BlackRock (BLK) Q3 Earnings and Revenues Surpass Estimates

BlackRock (BLK) came out with quarterly earnings of $11.55 per share, beating the Zacks Consensus Estimate of $11.19 per share. This compares to earnings of $11.46 per share a year ago. These

Why Congress Is Buying Intuitive Surgical Ahead of Earnings
Why Congress Is Buying Intuitive Surgical Ahead of Earnings

Intuitive Surgical Inc. (NASDAQ: ISRG) is entering a potential breakout window as it heads into its next earnings report on October 21, 2025. A wave of recent developments has improved the

Is Schwab Health Care Fund (SWHFX) a Strong Mutual Fund Pick Right Now?
Is Schwab Health Care Fund (SWHFX) a Strong Mutual Fund Pick Right Now?

If you have been looking for Sector - Health funds, a place to start could be Schwab Health Care Fund (SWHFX). SWHFX bears a Zacks Mutual Fund Rank of 2 (Buy), which is based on various forecasting

Is Morgan Stanley Inst Discovery I (MPEGX) a Strong Mutual Fund Pick Right Now?
Is Morgan Stanley Inst Discovery I (MPEGX) a Strong Mutual Fund Pick Right Now?

Having trouble finding a Mid Cap Growth fund? Morgan Stanley Inst Discovery I (MPEGX) is a potential starting point. MPEGX carries a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on